Regresar

Effect of Acetaminophen use during pregnancy on adverse pregnancy outcomes: a systematic review and meta-analysis

Abstract:

Introduction: A high number of women are exposed to acetaminophen during pregnancy worldwide. This drug safety during pregnancy regarding preterm birth, birth weight, and fetal development has not been well described. This study investigated the effect of acetaminophen use during pregnancy on selected adverse pregnancy outcomes. Areas covered: Databases were searched to identify studies reporting the effects of acetaminophen use during pregnancy on preterm birth, low birth weight, and small for gestational age. The studies’ quality was assessed by the Newcastle-Ottawa Scale and the Methodological Index for Non-Randomized Studies. Risk ratios with 95% confidence intervals were estimated using a fixed or random‐effects model. Six studies were included for final review, four cohort and two case‐control studies. We found no increased risk of preterm birth (RR 0.97; 95% CI 0.59–1.58), and decreased risks of low birth weight (RR 0.65; 95% CI 0.59–0.72) and small for gestational age (RR 0.69; 95% CI 0.50–0.97). Acetaminophen exposure during the third trimester revealed non-significantly in the outcomes. Expert opinion: Exposure to acetaminophen during pregnancy appears to not increase the risk of the outcomes analyzed. However, there is a lack of information regarding the exposure dose and frequency of acetaminophen use.